Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hospital-based rotavirus vaccination program for high-risk infants
NL-OMON21569Recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Dec 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of human rotavirus RIX4414 strain vaccine in rotaviral diarrhea (2 cohorts), sponsored by University Medical Center Utrecht. Primary endpoints: Impact on rotavirus-related hospitalizations and symptomatic nosocomial rotavirus infections, Vaccine effectiveness against severe rotavirus gastroenteritis and 1 more. Started Dec 2014; status: recruiting.
02
Drugs
human rotavirus RIX4414 strain vaccine
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on NL-OMON21569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21569.